2m 2m 2m 2m 2m 2m 2m
OWLET (OWLT)
NYSE
$4.95-$0.005 (-0.10%)
Price as of Jun 03, 2026 4:10 PM EDT- $160.4MMarket Cap
- -11.17%1-Year Change
- Medical DevicesIndustry
OWLET (OWLT)
$4.95-$0.005 (-0.10%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 105.7M +35.43% | 78.1M +44.52% | 54.0M -21.95% | 69.2M -8.76% | |
Cost of Revenue | 52.2M +34.65% | 38.7M +23.31% | 31.4M -31.52% | 45.9M +12.52% | |
Gross Profit | 53.5M +36.19% | 39.3M +74.03% | 22.6M -3.11% | 23.3M -33.50% | |
Sales and Marketing Expense | 18.5M +17.21% | 15.8M +16.51% | 13.5M -64.85% | 38.5M +3.79% | |
Research and Development Expense | -14.1M +43.62% | -9.8M -5.30% | -10.3M -62.90% | -27.9M +30.19% | |
Depreciation and Amortization Expense | 521,000 +15.27% | 452,000 -46.32% | 842,000 -40.62% | 1.4M +25.15% | |
Total Operating Expenses | 61.8M +3.81% | 59.5M +16.22% | 51.2M -52.55% | 107.9M +18.80% | |
Operating Profit | -8.3M -59.14% | -20.2M -29.38% | -28.6M -66.16% | -84.6M +51.67% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -3.4M +109.69% | -1.6M -48.92% | -3.2M +189.04% | -1.1M -37.70% | |
Interest Income and Expense and Net | -3.4M +109.69% | -1.6M -48.92% | -3.2M +189.04% | -1.1M -37.70% | |
Total Nonoperating Income and Expense | -31.4M -505.65% | 7.7M +281.69% | -4.3M -180.18% | 5.3M +133.45% | |
Income before Taxes | -39.6M +217.66% | -12.5M -62.05% | -32.9M -58.53% | -79.3M +10.65% | |
Income Taxes | 28,000 -48.15% | 54,000 +440.00% | 10,000 -65.52% | 29,000 -6.45% | |
Extraordinary Items | 46,000 -97.58% | 1.9M N/A | N/A N/A | N/A N/A | |
Net Income | -39.7M +216.51% | -12.5M -61.90% | -32.9M -58.53% | -79.3M +10.64% | |
Net Income from Continuing Operations Applicable to Common | -41.9M +143.10% | -17.2M -54.08% | -37.5M -52.73% | -79.3M +10.65% | |
Basic EPS and Net Income | -2.16 +37.58% | -1.57 -65.34% | -4.53 +538.03% | -0.71 -37.17% | |
Diluted EPS and Net Income | -2.16 +37.58% | -1.57 -65.34% | -4.53 +538.03% | -0.71 -37.17% | |
Basic Weighted Average Shares | 562,500 -94.86% | 11.0M +32.32% | 8.3M -92.56% | 111.3M +76.08% | |
Diluted Weighted Average Shares | 562,500 -94.86% | 11.0M +32.32% | 8.3M -92.56% | 111.3M +76.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 35.5M +75.16% | 20.2M +22.27% | 16.6M +47.42% | 11.2M -88.18% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 35.5M +75.16% | 20.2M +22.27% | 16.6M +47.42% | 11.2M -88.18% | |
Total Current Assets | 81.9M +77.64% | 46.1M +15.44% | 39.9M -22.08% | 51.3M -62.26% | |
Accumulated Depreciation | 2.7M -18.85% | 3.3M -3.40% | 3.4M +10.66% | 3.1M +60.39% | |
Property and Plant and Equipment and Net | 295,000 +189.22% | 102,000 -72.94% | 377,000 -65.97% | 1.1M -40.75% | |
Total Long-Term Assets | 2.0M -10.43% | 2.2M +233.89% | 655,000 -45.19% | 1.2M +79.43% | |
Total Assets | 85.6M +72.94% | 49.5M +12.22% | 44.1M -24.06% | 58.1M -58.51% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 6.9M +10.68% | 6.3M -58.78% | 15.2M +1.04% | 15.0M +76.21% | |
Total Current Liabilities | 44.2M +21.45% | 36.4M -19.21% | 45.1M -32.30% | 66.6M -3.60% | |
Total Long-Term Debt | 2.5M -43.13% | 4.3M -27.14% | 5.9M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 197,000 -12.83% | 226,000 -75.06% | 906,000 +260.96% | 251,000 -64.75% | |
Total Liabilities | 50.2M -24.35% | 66.3M -10.12% | 73.8M +7.36% | 68.7M -18.99% | |
Retained Earnings | -307.9M +14.79% | -268.2M +4.90% | -255.7M +14.77% | -222.8M +55.32% | |
Total Stockholders Equity | 19.0M +164.00% | -29.8M -20.73% | -37.5M +252.90% | -10.6M -119.27% | |
Total Shares Outstanding | 26.9M +71.35% | 15.7M +78.75% | 8.8M -92.38% | 115.4M +2.12% | |
Cash Flow | |||||
Cash from Operating Activities | -10.8M -3.72% | -11.2M -52.36% | -23.5M -71.09% | -81.4M +100.66% | |
Capital Expenditures | 273,000 +680.00% | 35,000 +118.75% | 16,000 -97.48% | 636,000 -34.37% | |
Cash from Investing Activities | -943,000 +23.92% | -761,000 +1,189.83% | -59,000 -96.23% | -1.6M -22.52% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 32.1M +100.17% | 16.0M -44.51% | 28.9M +3,392.94% | -878,000 -100.73% | |
Financials Ratio | |||||
Gross Margin | 50.64% +0.56% | 50.36% +20.42% | 41.82% +24.14% | 33.69% -27.12% | |
Operating Margin | -7.81% -69.83% | -25.90% -51.14% | -53.01% -56.65% | -122.28% +66.22% | |
Return on Assets | -58.72% +119.30% | -26.78% -58.40% | -64.37% -19.62% | -80.08% +107.53% | |
Return on Equity | 741.02% +1,888.57% | 37.26% -72.72% | 136.62% +138.36% | -356.12% +49.47% | |
Revenue Growth | 35.43% -20.43% | 44.52% +302.80% | -21.95% +150.75% | -8.75% N/A | |
Current Ratio | 1.85 +46.27% | 1.27 +42.88% | 0.89 +15.10% | 0.77 -60.85% | |
Cash Ratio | 0.80 +44.23% | 0.56 +51.33% | 0.37 +117.79% | 0.17 -87.75% | |
Debt-to-Equity Ratio | 0.49 +238.56% | -0.36 -36.77% | -0.56 -60.17% | -1.41 -572.12% | |
Debt-to-Assets Ratio | 0.11 -48.74% | 0.21 -55.33% | 0.48 +85.12% | 0.26 +119.32% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow